drugset / Trial / NCT03509350

Vitamin C, Thiamine, and Steroids in Sepsis

NCT03509350

Phase 3 Completed 501 enrolled Emory University The Marcus Foundation · collab
RandomizedParallel-groupDouble-blindSupportive care

Summary

The VItamin C, Thiamine And Steroids in Sepsis (VICTAS) Study is a double-blind, placebo-controlled, adaptive randomized clinical trial designed to investigate the efficacy of the combined use of vitamin C, thiamine and corticosteroids versus indistinguishable placebos for patients with sepsis. The objective of this study is to demonstrate the efficacy of combination therapy using vitamin C, thiamine and corticosteroids in reducing mortality and improving organ function in critically ill patients with sepsis.

Timeline

Start
2018-08-22
Primary completion
2019-08-22
Completion
2020-01-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 50 mg Intravenous
Subject Thiamine Other / unclassified 100 mg Intravenous
Subject Vitamin C Other / unclassified 1.5 g Intravenous